Recruiting

4

1428

RoW

Indomethacin SR, YINDUOMEIXIN, Placebos, sham

Peking Union Medical College Hospital

Acute Pancreatitis, Complication, Mortality Rate, Organ Failure, Multiple

06/28

06/30

Recruiting

3

120

RoW

FRSW117, Recombinant human coagulation factor Ⅷ-Fc fusion protein for injection

Jiangsu Gensciences lnc.

Severe Hemophilia A

01/26

09/26

Active, not recruiting

3

150

RoW

SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone)

Antengene Corporation

Relapsed or Refractory Multiple Myeloma

07/24

10/24

Recruiting

2/3

470

RoW

Loperamide, Loperamide and golden bifid, Loperamide and montmorillonite powder

Tianjin Medical University Cancer Institute and Hospital

Breast Cancer

10/22

04/23

Not yet recruiting

2

50

RoW

Yangzheng Xiaoji, Niraparib

Sichuan Cancer Hospital and Research Institute

Ovarian Cancer

10/23

05/25

Active, not recruiting

2

112

Europe, US, RoW

Selinexor, Physician's Choice Treatment

Karyopharm Therapeutics Inc

Myelofibrosis

01/25

01/25

Recruiting

1/2

430

RoW

IBI363, IBI325, Lenvatinib

Hunan Province Tumor Hospital, Xiangya Hospital of Central South University

Advanced Solid Tumor

12/26

09/28

Recruiting

N/A

200

RoW

XueBiJing Injection, Normal saline

Nanjing Medical University

Cardiovascular Disease, Aortic Dissection, Coronary Artery Disease, Valve Heart Disease, Congenital Heart Disease, Critical Illness

12/22

12/22

Recruiting

N/A

15

RoW

Affiliated Hospital of Nantong University

Folate, CML, Treatment-free Remission

06/23

12/23

Completed

N/A

106

RoW

Remimazolam, Rema, Esketamine, Esket, Propofol, Prop, remifentanil, remifen

Tongji Hospital

Drug Effect

07/23

07/23

Recruiting

N/A

200

RoW

Thymosin Alpha1, Blank Control

Nanjing Medical University

Rheumatic Heart Disease, Cardiopulmonary Bypass, Immunotherapy

12/23

12/23

Recruiting

N/A

16000

RoW

phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2

Wuhan Union Hospital, China, Peking University First Hospital

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease

12/23

12/24

Recruiting

N/A

500

RoW

Sivelestat, Blank control

Nanjing Medical University, The First Affiliated Hospital with Nanjing Medical University, Beijing Anzhen Hospital

Aortic Dissection, Systemic Inflammatory Response Syndrome, Cardiovascular Diseases (CVD)

12/25

12/25

Not yet recruiting

N/A

500

RoW

Remote ischemic preconditioning (RIPC), sham condition (control group)

Nanjing Medical University, The First Affiliated Hospital with Nanjing Medical University

Cardiopulmonary Bypass, Cardiovascular Diseases, Inflammatory Response During Cardiac Surgery

12/25

12/25

Not yet recruiting

N/A

120

RoW

Angong Niuhuang Pill (ANP), Control (Standard treatment)

Nanjing Medical University, The First Affiliated Hospital with Nanjing Medical University, Beijing Anzhen Hospital, Capital Medicine University

Cardio-pulmonary Bypass, Cardiovascular Surgery, Cerebral Protection, Brain Injury

12/25

12/25

Recruiting

N/A

5000

US

University of California, Davis

Coronary Artery Disease, Valvular Diseases, Vascular Diseases

02/25

07/25

Enrolling by invitation

N/A

10000

RoW

observation

Nanjing Medical University, Beijing Anzhen Hospital

Acute Aortic Syndrome

12/40

12/40

Enrolling by invitation

N/A

500

RoW

Intestinal Microbiota Transplant (IMT) Capsules

Nanjing Medical University, Beijing Anzhen Hospital, Shanghai East Hospital of Tongji University, West China Hospital, The First Affiliated Hospital of Guangzhou Medical University

Cardiovascular Disease, Cardiopulmonary Bypass

12/25

12/25

Recruiting

N/A

336

RoW

Endovascular treatment, Intravenous thrombolysis (Alteplase)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment

01/27

05/27

Recruiting

N/A

2000

RoW

Observational study, no intervention

Nanfang Hospital of Southern Medical University, First Affiliated Hospital of Fujian Medical University, Yantai Yuhuangding Hospital, The First Hospital of Jilin University, Qilu Hospital of Shandong University, ZHEJIANG PROVINCE XIAOSHAN HOSPITAL, The First People's Hospital of Wenling, Ganzhou People's Hospital, Affiliated Hospital of Jining Medical hospital, Henan Provincial People's Hospital, Zhongda Hospital Southeast University, The Second Affiliated Hospital of Harbin Medical University, The First people's Hospital of Kunshan, The 2nd Affiliated Hospital of Wenzhou Medical University, THE FIRST PEOPLE'S HOSPITAL OF JIASHAN, The First Affiliated Hospital of Xi'an Jiaotong University Medical College, Fujian Province Zhangzhou Hospital, People's Hospital of Chongqing, Nanjing Zijin Hospital, Hangzhou Red Cross Hospital, Wenzhou Hospital of Chinese Medicine, Kaifeng Central Hospital, First Affiliated Hospital of Guangxi Medical University, Zhongshan Hospital of Xiamen University, Xi'an Encephalopathy of Traditional Chinese Medicine Hospital, 903 Hospital of the Chinese People's Liberation Army Joint Logistics and Security Forces, Xiangya Hospital of Central South University, Second Affiliated Hospital of Suzhou University, Tongji Hospital, The Affiliated Hospital o fQingdao University, The First Affiliated Hospital of Anhui Medical University, Yancheng Third People's Hospital, Linyi People's Hospital, Dongfang Hospital of Beijing University of Chinese Medicine, Affiliated Hospital of Qingdao University

Acute Stroke

10/22

10/23

Recruiting

N/A

300

RoW

ECMO

Nanjing Medical University

Cardiogenic Shock, Cardiac Arrest, Heart Failure, Acute Respiratory Failure, Acute Respiratory Distress Syndrome

12/25

12/25